CENTEK(000931)
Search documents
“海”好有你中关村校招季启动
Bei Jing Ri Bao Ke Hu Duan· 2025-10-18 22:45
Group 1 - The event "Hai Hao You Ni - Zhongguancun Campus Recruitment Season" kicked off in the Beijing-Zhangjiakou Railway Ruins Park, featuring over 80 well-known companies and institutions from Haidian District offering more than 1,000 quality job positions [1][2] - The recruitment fair attracted participation from over 1,000 young students from more than 50 universities, showcasing a strong demand for talent in cutting-edge fields, particularly in artificial intelligence [1][2] - The event is set to continue until March 2026, with more than ten dual-selection activities planned, releasing over 10,000 recruitment demands [2] Group 2 - Notable participating companies include Xiaomi, Huawei, Baidu, Tencent, and Meituan, indicating a strong presence of major tech firms in the recruitment landscape [1][2] - A "Corporate Mentor Team" consisting of representatives from five companies, including Xiaomi and Huawei, was present to provide guidance and support to students, emphasizing the importance of retaining talent in Haidian [2] - The recruitment fair also expanded its reach by setting up a sub-venue in Hong Kong and simultaneously releasing job postings in Singapore, aiming to attract global talent [2]
“中关村兄弟”刘强东和雷军,终于在造车领域遭遇了
Sou Hu Cai Jing· 2025-10-16 23:18
Core Insights - Liu Qiangdong and Lei Jun are both entering the automotive industry, marking a significant development in their entrepreneurial journeys [2][6] - JD.com announced a collaboration with GAC Group and CATL to launch the "National Good Car," focusing on consumer insights and exclusive sales rather than direct manufacturing [3][4] - JD.com has been strategically positioning itself in the automotive sector for years, with various initiatives and investments since 2015 [4][5] Company Strategy - JD.com will act as an "ecosystem integrator," leveraging big data to understand consumer preferences while GAC handles manufacturing and CATL focuses on battery technology [3][14] - The "National Good Car" aims to address key consumer concerns such as safety, range, and price, with a planned test drive event at the end of October [3][14] - JD.com has developed a comprehensive automotive service ecosystem, including an online vehicle trading platform and a focus on after-sales services [4][13] Competitive Landscape - Liu Qiangdong's approach contrasts with Lei Jun's high-profile strategy; JD.com is taking a more understated route by not directly manufacturing vehicles [6][13] - Both entrepreneurs recognize the automotive sector's potential as a new consumer and logistics frontier, but they are pursuing different paths based on their core competencies [14][19] - JD.com is positioning itself as a supply chain infrastructure provider for the automotive industry, focusing on logistics and service rather than vehicle production [13][14] Market Positioning - JD.com has been expanding its business into various sectors, including food delivery, health, and robotics, indicating a broader strategy beyond e-commerce [5][19] - The company is leveraging its strong supply chain and logistics capabilities to create a comprehensive ecosystem that integrates retail, services, technology, and transportation [19] - JD.com's recent moves in the automotive sector reflect a strategic shift towards building a full-service ecosystem, aiming to reshape the industry landscape [19]
中关村丰台科技园新商业地标亮相
Bei Jing Ri Bao Ke Hu Duan· 2025-10-16 09:29
转自:北京日报客户端 10月16日,位于中关村丰台科技园的北京鑫嘉汇购物中心揭牌重新亮相。 作为集体经济转型升级的标杆项目,鑫嘉汇以"家庭欢聚场"为核心定位,通过空间改造与业态重组满足 区域消费需求。覆盖周边3公里人群,叠加中关村丰台科技园高新技术企业集群与世界公园旅游客流, 形成"家庭+商务+旅游"三元消费生态。 为此,鑫嘉汇将外广场、中庭等区域升级为亲子互动与社交活动场地,并引入运动健康、全时段餐饮等 新业态,弥补区域商业功能空白。 来源:北京日报客户端 ...
中关村涨2.11%,成交额2141.47万元,主力资金净流入71.93万元
Xin Lang Zheng Quan· 2025-10-15 02:29
Core Viewpoint - Zhongguancun's stock price has shown a mixed performance in recent trading sessions, with a year-to-date increase of 11.97% and a slight decline over the past 20 and 60 days, indicating volatility in its market performance [2]. Group 1: Stock Performance - On October 15, Zhongguancun's stock rose by 2.11%, reaching a price of 5.33 CNY per share, with a trading volume of 21.41 million CNY and a turnover rate of 0.54% [1]. - The stock has increased by 1.14% over the last five trading days, but has decreased by 0.74% over the past 20 days and 1.84% over the last 60 days [2]. Group 2: Financial Overview - For the first half of 2025, Zhongguancun reported a revenue of 1.239 billion CNY, reflecting a year-on-year decrease of 2.71%, while the net profit attributable to shareholders was 38.81 million CNY, showing a year-on-year increase of 6.65% [2]. - The company has distributed a total of 270 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [2]. Group 3: Company Profile - Zhongguancun Technology Development (Holding) Co., Ltd. was established on June 8, 1999, and listed on July 12, 1999. Its main business areas include pharmaceuticals, concrete, and real estate [2]. - The company's revenue composition is primarily from product sales (93.94%) and service provision (6.06%) [2]. - Zhongguancun is classified under the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and preparations, and is associated with concepts such as traditional Chinese medicine and the elderly care industry [2].
中 关 村(000931) - 关于控股股东及其一致行动人部分股份延长司法再冻结期限、一致行动人部分股份司法再冻结到期及轮候冻结生效的公告
2025-10-14 08:45
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 近日,北京中关村科技发展(控股)股份有限公司(以下简称:公司)通过 中国证券登记结算有限责任公司查询,获悉: 公司控股股东国美控股集团有限公司(以下简称:国美控股)现持有公司 186,113,207 股,持股比例为 24.71%;国美控股所持有公司的部分股份被法院延 长司法再冻结期限。 国美电器有限公司(以下简称:国美电器)作为国美控股的一致行动人,现 持有公司 50,000,000 股,持股比例为 6.64%;国美电器所持有公司的部分股份被 法院延长司法再冻结期限,部分股份司法再冻结到期,前期被轮候冻结的股份生 效,具体情况如下: 1 股东名称 是否为控 股股东或 第一大股 东及其一 致行动人 司法再冻 结数量 (股) 占其所 持股份 比例 占公司 总股本 比例 司法再冻结 起始日 原司法再冻 结到期日 司法再冻结 到期日(延 期后) 司法再冻结执 行人 国美控股集 团有限公司 是 400,000 0.21% 0.05% 2022-10-10 2025-10-09 2028-09-25 北京市第三中 级人民法院 ...
中 关 村(000931) - 关于下属公司多多药业西格列汀二甲双胍片(II)收到国家药品监督管理局《受理通知书》的公告
2025-10-14 08:00
北京中关村科技发展(控股)股份有限公司(以下简称:公司)下属公司 多多药业有限公司(以下简称:多多药业)于近日收到国家药品监督管理局(以 下简称:国家药监局)签发的《受理通知书》,西格列汀二甲双胍片(II)(规 格:每片含磷酸西格列汀 50mg(以西格列汀计)和盐酸二甲双胍 850mg)上市 许可申请获得受理,现将相关情况公告如下: 一、基本信息 关于下属公司多多药业西格列汀二甲双胍片(II)收到国家药品监督管理局《受理通知书》的公告 共 2 页 证券代码:000931 证券简称:中关村 公告编号:2025-111 北京中关村科技发展(控股)股份有限公司 关于下属公司多多药业西格列汀二甲双胍片(II)收到 国家药品监督管理局《受理通知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 药品名称:西格列汀二甲双胍片(II) 剂型:片剂 规格:每片含磷酸西格列汀 50mg(以西格列汀计)和盐酸二甲双胍 850mg 申请事项:境内生产药品注册上市许可 注册分类:化学药品 4 类 申请人:多多药业有限公司 受理号:CYHS2503626 结论:经审查,决定予以 ...
中关村下属公司西格列汀二甲双胍片(II)上市许可申请获得受理
Zhi Tong Cai Jing· 2025-10-14 07:55
多多药业西格列汀二甲双胍片(II)(规格:每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍 850mg)于2023年立项开发,其适应症为:本品配合饮食和运动治疗,用于经二甲双胍单药治疗血糖仍 控制不佳或正在接受二者联合治疗的2型糖尿病患者。 中关村(000931)(000931.SZ)发布公告,公司下属公司多多药业有限公司(以下简称:多多药业)于近日 收到国家药品监督管理局(以下简称:国家药监局)签发的《受理通知书》,西格列汀二甲双胍片(II)(规 格:每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍850mg)上市许可申请获得受理。 ...
中关村:西格列汀二甲双胍片(II)收到《受理通知书》
Ge Long Hui· 2025-10-14 07:54
格隆汇10月14日丨中关村(000931.SZ)公布,下属公司多多药业有限公司(简称:多多药业)于近日收 到国家药品监督管理局签发的《受理通知书》,西格列汀二甲双胍片(II)(规格:每片含磷酸西格列 汀50mg(以西格列汀计)和盐酸二甲双胍850mg)上市许可申请获得受理。多多药业西格列汀二甲双 胍片(II)(规格:每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍850mg)于2023年立项 开发,其适应症为:本品配合饮食和运动治疗,用于经二甲双胍单药治疗血糖仍控制不佳或正在接受二 者联合治疗的2型糖尿病患者。 ...
中关村(000931.SZ)下属公司西格列汀二甲双胍片(II)上市许可申请获得受理
智通财经网· 2025-10-14 07:54
多多药业西格列汀二甲双胍片(II)(规格:每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍 850mg)于2023年立项开发,其适应症为:本品配合饮食和运动治疗,用于经二甲双胍单药治疗血糖仍 控制不佳或正在接受二者联合治疗的2型糖尿病患者。 智通财经APP讯,中关村(000931.SZ)发布公告,公司下属公司多多药业有限公司(以下简称:多多药业) 于近日收到国家药品监督管理局(以下简称:国家药监局)签发的《受理通知书》,西格列汀二甲双胍片 (II)(规格:每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍850mg)上市许可申请获得受理。 ...
中关村:下属公司西格列汀二甲双胍片(II)上市许可申请获受理
Zheng Quan Shi Bao Wang· 2025-10-14 07:51
Core Viewpoint - The company Zhongguancun (000931) has received acceptance for the marketing authorization application of its drug, Sitagliptin Metformin Tablets, from the National Medical Products Administration, indicating a significant step in expanding its product portfolio in the diabetes treatment market [1] Company Summary - Zhongguancun's subsidiary, Duoduo Pharmaceutical Co., Ltd., has recently received the acceptance notice for the marketing authorization application of Sitagliptin Metformin Tablets [1] - The drug is indicated for the treatment of type 2 diabetes patients who have inadequate blood sugar control with metformin monotherapy or are currently receiving a combination of both treatments [1] Industry Summary - The acceptance of the drug application highlights the ongoing demand and market potential for diabetes medications, particularly for combination therapies that enhance blood sugar control [1] - The drug contains 50mg of Sitagliptin and 850mg of Metformin per tablet, which aligns with current treatment protocols for managing type 2 diabetes [1]